Anti-sialic acid antibody molecules
AssigneeDublin City University
InventorsGerard Gary Donohoe, Barry Byrne, Stephen Henry Hearty, Richard O'Kennedy
Life of this patent
Estimating the term…
Loading patent…
AssigneeDublin City University
InventorsGerard Gary Donohoe, Barry Byrne, Stephen Henry Hearty, Richard O'Kennedy
Estimating the term…
A method of generating and isolating a recombinant high affinity anti-sialic acid antibody molecule comprises the steps of immunising a host with an immunogen comprising a conjugate of sialic acid and a carrier protein to generate an anti-sialic acid polyclonal serum, isolating a sample of RNA from the immunised avian host, and generating and screening of a library of recombinant antibody molecules from the RNA sample, and isolating a recombinant high affinity anti-sialic acid antibody molecule. The antibody molecule is selected from the group consisting of: whole antibodies; scFv fragments; and Fab fragments, and the host is Gallus domesticus. A recombinant avian antibody fragment having high binding affinity to sialic acid and obtainable by the method of the invention, and an anti-sialic acid polyclonal serum obtainable by immunising an avian host with a conjugate of sialic acid and carrier protein, are also described.
A method of generating and isolating a recombinant high affinity anti-sialic acid antibody molecule, the method comprising:
An anti-sialic acid polyclonal serum obtainable by immunising a host with a conjugate of sialic acid and carrier protein, wherein the host glycome is deficient in the sialic acid.
A conjugate of sialic acid and a carrier protein in which the conjugate comprises at least two sialic acid molecules and one carrier protein molecule.
An isolated, recombinant anti-sialic acid antibody molecule or fragment having a nanomolar binding affinity to sialic acid.
Dependencies are inferred from the claim text.